Pembrolizumab
SPON 1529-16
Phase 1 small_molecule active
Quick answer
Pembrolizumab for Anal Cancer Stage III A is a Phase 1 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiff Oncology
- Indication
- Anal Cancer Stage III A
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active